Sermorelin: Boost Growth. Sleep Better. Recover Stronger.

Sermorelin: Boost Growth. Sleep Better. Recover Stronger.

FSA / HSA Eligible

$225 / Month

Any Dose

  • No insurance needed

  • Transparent pricing

  • FSA/HSA Eligible

  • 100% Online

  • No Hidden Fees

Unlock Your Body’s Natural Growth Potential

Looking for a way to naturally revitalize your body’s vital processes? Nucore’s Sermorelin therapy offers a powerful, cutting-edge approach that works with your body. Sermorelin is a synthetic peptide that mimics your natural Growth Hormone-Releasing Hormone (GHRH), sending a direct signal to your pituitary gland to safely stimulate the release of your own endogenous Growth Hormone. This natural, pulsatile release is associated with benefits like improved post-exercise recovery, enhanced vitality, and support for better body composition (maintaining muscle and reducing fat). Sermorelin is administered through a simple subcutaneous injection, often recommended at night to align with the body’s natural cycle. Choose Sermorelin to tap into your natural potential and safely revitalize from within.

Frequently Asked Questions

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release endogenous growth hormone. [1-2]

With Sermorelin therapy, you may experience the benefit of increased muscle composition and strength, stronger bones, higher energy levels, and enhanced sleep quality. [2]

Sermorelin is given either subcutaneously for therapeutic purposes, typically at bedtime. [3]

The most frequently reported side effects are transient facial flushing and pain at the injection site; overall, it is well tolerated.[4-5]

Sermorelin is available through our network is compounded by state-licensed pharmacies and is not FDA-approved to treat or prevent any specific condition. Nucore does not manufacture or dispense medications but connects patients with licensed providers for consultation and potential treatment options.

References

Montero-Hidalgo, A. J., Del Rio-Moreno, M., Pérez-Gómez, J. M., Luque, R. M., & Kineman, R. D. (2025). Update on regulation of GHRH and its actions on GH secretion in health and disease. Reviews in endocrine & metabolic disorders, 26(3), 305–320.

https://doi.org/10.1007/s11154-025-09943-y

Tavares, A. B., Micmacher, E., Biesek, S., Assumpção, R., Redorat, R., Veloso, U., Vaisman, M., Farinatti, P. T., & Conceição, F. (2013). Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old. International journal of endocrinology, 2013, 942030.

https://doi.org/10.1155/2013/942030

Schally, A. V., Zhang, X., Cai, R., Hare, J. M., Granata, R., & Bartoli, M. (2019). Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists. Endocrinology, 160(7), 1600–1612.

https://doi.org/10.1210/en.2019-00111

Prakash, A., & Goa, K. L. (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 12(2), 139–157.

https://doi.org/10.2165/00063030-199912020-00007 

Laron Z. (1995). Growth hormone secretagogues. Clinical experience and therapeutic potential. Drugs, 50(4), 595–601.

https://doi.org/10.2165/00003495-199550040-00002 

Important Disclaimer

These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

Experience The Future Of Metabolic Optimization With Nucore.